In the present study, we found that the GcG mRNA levels in the WD group were decreased, despite increased Tcf7l2 gene expression (Figure 2A), which suggests an intracellular signaling defect distal to or independent of TCF7L2, or the presence of other more important factors for regulating intestinal GcG expression. This evidence concerns the gene TCF7L2 and Wilson disease.